Pancreatic Cancer Research

ResearcherUniversity of PaviaActive in the last 2 years

Lorenzo Gervaso

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3313-8527; OpenAlex author ID A5062592912. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project. Co-author DOI 10.1093/ije/dyag064↗
  2. Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis. First author DOI 10.1016/j.ctrv.2022.102338↗
  3. Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom? Co-author DOI 10.1001/jamaoncol.2021.3603↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nicola Fazio · 3 shared papers, 2021–2026 · strength 0.60
  2. Florian Lordick · 1 shared paper, 2021 · strength 0.22
  3. Serena Oliveri · 1 shared paper, 2026 · strength 0.21
  4. Mireia Obón‐Santacana · 1 shared paper, 2026 · strength 0.21
  5. Cindy Canivet · 1 shared paper, 2026 · strength 0.21
  6. Lois Riobó‐Mayo · 1 shared paper, 2026 · strength 0.21
  7. Louis Buscail · 1 shared paper, 2026 · strength 0.21
  8. Barbara Bournet · 1 shared paper, 2026 · strength 0.21
  9. Victor Rau Moreno · 1 shared paper, 2026 · strength 0.21
  10. Mónica Isabel Meneses Medina · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.